• Home
  • Conference News
    • Pre-Coverage
    • Conference Coverage
    • Post Coverage
    • Archives
      • 2024
      • 2023
      • 2022
  • Industry
  • Industry Programs
    • Innovation Theaters
    • Innovation Hubs
    • Evening Symposia
  • Industry Connections
  • Publications
    • Preview Magazine
    • On-Site Guide
  • Photos
  • Program at a Glance
  • Special Topics
    • Allergy and Immunology
    • Bronchiectasis and COPD
  • Follow The ATS
    • Facebook
    • BlueSky
    • LinkedIn
    • Instagram
    • X
    • YouTube
  • Get News Updates

ATS Conference News

San Francisco | May 16-21

We help the world breathe.

GET NEWS UPDATES
CONFERENCE HOME
REGISTER NOW
  • ATS 2023 Goes to Washington

    ATS 2023 Goes to Washington

    on

    06/27/2022

    Save the date: The International Conference will return to Washington, D.C., May 19-24, 2023, to showcase the latest advances in understanding pulmonary disease, critical illness, and sleep disorders from scientists and clinicians at all stages of their careers.

    Read more: ATS 2023 Goes to Washington
  • June 24 Is Last Day to View ATS 2022: On-Demand Highlights

    June 24 Is Last Day to View ATS 2022: On-Demand Highlights

    on

    06/17/2022

    The virtual platform provides convenient, on-demand access to popular scientific sessions from the International Conference, including Year in Review and Core Curriculum sessions; industry presentations from leading companies in the field; and thousands of ePosters highlighting the latest discoveries in pulmonary, critical care, and sleep medicine.

    Read more: June 24 Is Last Day to View ATS 2022: On-Demand Highlights
  • Pediatric Core Curriculum Focuses on Lung Involvement in Neuromuscular Disease

    Pediatric Core Curriculum Focuses on Lung Involvement in Neuromuscular Disease

    on

    06/17/2022

    Oren Kupfer, MD, opened the first of three sessions with an exploration of diagnostic strategies to identify NMDs as a prelude to managing and treating these diseases. “Respiratory disease is common in our patients with neuromuscular disease and is often the cause of death,” he said.

    Read more: Pediatric Core Curriculum Focuses on Lung Involvement in Neuromuscular Disease
  • Panel Examines Career Development Challenges in Wake of COVID-19 Pandemic

    Panel Examines Career Development Challenges in Wake of COVID-19 Pandemic

    on

    06/17/2022

    Jamuna K. Krishnan, MD, MBA, MSc; Neeta Thakur, MD, MPH; Juan C. Celedon, MD, DrPH, ATSF; and Sushma K. Cribbs, MD, MSCR, ATSF, discussed pre-existing threats to and the collateral effects of COVID-19 on professional development for young respiratory health faculty.

    Read more: Panel Examines Career Development Challenges in Wake of COVID-19 Pandemic
  • Learn and Connect Through ATS Membership

    Learn and Connect Through ATS Membership

    on

    06/17/2022

    More than 16,000 health care providers and researchers around the world belong to the ATS, the preeminent respiratory society in pulmonary, critical care, and sleep medicine. Be part of the Society’s mission to accelerate global innovation in the advancement of respiratory health through multidisciplinary collaboration, education, and advocacy by becoming a member today.

    Read more: Learn and Connect Through ATS Membership
  • Session Offers Patient, Clinician Perspectives on Long-Term Effects of COVID-19

    Session Offers Patient, Clinician Perspectives on Long-Term Effects of COVID-19

    on

    06/09/2022

    In addition to the physical effects of COVID-19 infection on patients, the pandemic has had a significant impact on the well-being of frontline health care workers. Experts including Heather De Keyser, MD, MSCR, discussed the implications of both for public health.

    Read more: Session Offers Patient, Clinician Perspectives on Long-Term Effects of COVID-19
  • Pulmonary Clinical Core Sessions Focus on Interstitial and Fibrotic Lung Diseases

    Pulmonary Clinical Core Sessions Focus on Interstitial and Fibrotic Lung Diseases

    on

    06/09/2022

    Panelists Erica Farrand, MD; Bridget Collins, MD; Leticia Kawano-Dourado, MD, PhD; Ayodeji Adegunsoye, MD, MS; and Robert W. Hallowell, MD, explained the complexities of the diagnosis and treatment of diseases including pulmonary fibrosis and granulomatous lymphocytic interstitial lung disease, as well as autoimmune rheumatic diseases with pulmonary manifestations.

    Read more: Pulmonary Clinical Core Sessions Focus on Interstitial and Fibrotic Lung Diseases
  • Clinical Year in Review 1: Panelists Review the Year’s Top Papers in PVD, ILD, Lung Cancer, and Pneumonia

    Clinical Year in Review 1: Panelists Review the Year’s Top Papers in PVD, ILD, Lung Cancer, and Pneumonia

    on

    06/09/2022

    Manuel Sánchez De La Torre, PhD, discussed obstructive sleep apnea phenotypes in a scientific symposium addressing the integration of endotypes, medical informatics, and multi-omics to guide more precise care of patients with sleep disorders. Presenters also discussed sex-specific factors as targets for subtyping, epigenomics, and designing new trials.

    Read more: Clinical Year in Review 1: Panelists Review the Year’s Top Papers in PVD, ILD, Lung Cancer, and Pneumonia
  • Critical Care Curriculum Sessions Address ICU Delirium, PICS

    Critical Care Curriculum Sessions Address ICU Delirium, PICS

    on

    06/02/2022

    Two symposia in the Critical Care Clinical Core Curriculum focused on recognizing, avoiding, and managing the impairments that can develop after admission to an intensive care unit.

    Read more: Critical Care Curriculum Sessions Address ICU Delirium, PICS
  • Experts Review History of E-Cigarettes and Mechanisms of Vaping-Associated Lung Illness

    Experts Review History of E-Cigarettes and Mechanisms of Vaping-Associated Lung Illness

    on

    06/02/2022

    Enid R. Neptune, MD, ATSF, was part of an international panel that discussed the needed clinical, public health, and regulatory efforts to prevent future e-cigarette induced lung injury.

    Read more: Experts Review History of E-Cigarettes and Mechanisms of Vaping-Associated Lung Illness
1 2 3 … 9
Next Page

Follow The ATS

  • Bluesky
  • Facebook
  • LinkedIn
  • Instagram
  • X
  • YouTube
  • TikTok

Upcoming Industry Programs

View All

Popular Articles

  • Experts Encourage ATS Attendees to Take Action for Air Quality at Tuesday’s Keynote

  • Monday Keynote Presents Exciting Progress in Gene Therapies for Cystic Fibrosis

  • Women’s Forum Speaker Reflects on the Meaning of Success, Purpose, and the Future of Female Leadership in Medicine

  • Breaking Clinical Trials Session Unveils New Insights in Pulmonary Medicine

  • Meet the 2025 Respiratory Health Awards Recipients

©2025 American Thoracic Society. All Rights Reserved. Powered by TriStar Event Media, LLC.
Privacy Policy

FOLLOW THE ATS:

  • Bluesky
  • Facebook
  • LinkedIn
  • Instagram
  • X
  • YouTube
  • TikTok

Get news updates from ATSConferenceNews.org

Subscribe below to get email updates from ATSConferenceNews.org